Company Monitoring Page for Biogen

latest headlines for company on cafepharma

Moody's picks 5 early winners in biosimilar market
Biopharma Dive
Fri, 10/5/18 - 09:01 pm
Tags:
biosimilars, Pfizer, Biogen, Novartis, Amgen, Mylan Labs
Parkinson's Patient Files Discrimination Lawsuit Against Biogen, Adding to Other Former Employee Suits
BioSpace
Fri, 10/5/18 - 12:05 pm
Tags:
Biogen, discrimination, disabilities, Parkinson's Disease
AbbVie's not the only one facing kickbacks scrutiny. Add Biogen, Sanofi, Gilead and more
Fierce Pharma
Tue, 09/25/18 - 07:19 pm
Tags:
AbbVie, Biogen, Sanofi, Gilead Sciences
Biogen, Teva benefit as payers ease up on multiple sclerosis meddling: analyst
Fierce Pharma
Fri, 08/31/18 - 11:44 pm
Tags:
Biogen, Teva Pharmaceutical, MS, multiple sclerosis, payers
Biogen and Eisai Report Phase Ib Extension Data for Alzheimer’s Trial
BioSpace
Tue, 08/28/18 - 07:54 pm
Tags:
Biogen, Eisai, aducanumab, clinical trials, Alzheimer's disease
Biogen's Spinraza gets an early no-go from NICE
Biopharma Dive
Wed, 08/15/18 - 09:57 am
Tags:
Biogen, UK, NICE, Spinraza, SMA, spinal muscular atrophy
Why Biogen's Stock Ripped Higher in July
Motley Fool
Mon, 08/13/18 - 09:41 am
Tags:
Biogen, Eisai, BAN2401, Alzheimer's disease, Spinraza, Ionis Pharmaceuticals
Biogen’s high-stakes Alzheimer’s gamble is being roasted by the experts. Is the amyloid beta theory dead?
Endpoints
Thu, 08/9/18 - 09:16 am
Tags:
Biogen, Eisai, BAN2401, Alzheimer's disease
FOCUS-Eisai/Biogen to advance Alzheimer's drug, provide fresh hope
Yahoo/Reuters
Sun, 08/5/18 - 12:22 pm
Tags:
Biogen, Eisai, Alzheimer's disease, BAN2401
Why the Latest Alzheimer’s Drug Study Has So Many People Confused
Fortune
Mon, 07/30/18 - 11:54 pm
Tags:
Biogen, Eisai, BAN2401, clinical trials, Alzheimer's disease
Ex-Biogen territory manager claims she was fired after filing integrity complaint
Fierce Pharma
Mon, 07/30/18 - 11:11 pm
Tags:
Biogen, drug reps, off label, Zinbryta
Collaborations Help Alkermes Flip to Profitability
Motley Fool
Fri, 07/27/18 - 07:09 pm
Tags:
Alkermes, Biogen, earnings
Eisai, Biogen outline a 30% and 47% advantage for their Alzheimer’s drug BAN2401 — but critics drag stock down
Endpoints
Wed, 07/25/18 - 05:11 pm
Tags:
Biogen, Eisai, Alzheimer's disease, BAN2401, clinical trials
Biogen wants you to know it's more than BAN2401
Biopharma Dive
Tue, 07/24/18 - 11:36 pm
Tags:
Biogen, BAN2401
As Eisai, Biogen plot a course to accelerated approvals for Alzheimer’s drug, a mob of skeptics are waiting to decipher hard numbers
Endpoints
Tue, 07/24/18 - 11:30 am
Tags:
Eisai, Biogen, Alzheimer's disease, BAN2401, AAIC
Biogen Jumps on Earnings Beat Ahead of Alzheimer's Presentation
TheStreet.com
Tue, 07/24/18 - 11:21 am
Tags:
Biogen, earnings
Report: Biogen CEO eyes medical device market
Drug Delivery Business News
Mon, 07/23/18 - 11:27 am
Tags:
Biogen, devices
Biogen: Analysts’ Views before Its Second-Quarter Results
Market Realist
Mon, 07/23/18 - 09:41 am
Tags:
Biogen, earnings
7 companies to watch during Q2 earnings
Biopharma Dive
Sun, 07/22/18 - 12:41 pm
Tags:
earnings, Biogen, Gilead Sciences, Amgen, Celgene, AbbVie, Pfizer, Spark Therapeutics
AAIC event – Biogen and Eisai move to consolidate beta-amyloid lead
EP Vantage
Tue, 07/17/18 - 11:20 pm
Tags:
Biogen, Eisai, BAN2401, Alzheimer's disease

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.